Apolipoprotein E-4 genetic (DNA) test
Research into ways to test DNA (genes) to see if a person is likely to develop Alzheimer's disease is progressing rapidly.
People who have a gene for apolipoprotein E-4 (ApoE-4) may be more likely to develop the disease, but the presence of the gene cannot predict for sure whether a person will develop Alzheimer's disease. Many people who have the ApoE-4 gene do not get Alzheimer's disease, and many people who do not have the gene still develop the disease.
At this time, routine genetic testing for ApoE-4 is not recommended. 1 Knowing that a person has ApoE-4 means only that the person may be at increased risk for Alzheimer's disease. There most likely are several other factors that contribute to whether a person develops the disease. Most experts do not consider ApoE-4 testing a necessary or useful part of evaluating a person with suspected Alzheimer's disease.
Genetic testing is being used mostly in research centers to decide whether the test may be useful for more general screening.
References
Citations
Credits
| Author | Sabra L. Katz-Wise |
| Author | Ralph Poore |
| Editor | Susan Van Houten, RN, BSN, MBA |
| Associate Editor | Pat Truman |
| Primary Medical Reviewer | Adam Husney, MD - Family Medicine |
| Primary Medical Reviewer | Kathleen Romito, MD - Family Medicine |
| Specialist Medical Reviewer | Peter J. Whitehouse, MD - Neurology |
| Last Updated | November 15, 2006 |
| Last updated: | November 15, 2006 |
|---|---|
| Author: | Ralph Poore |
| Reviewed By: | Kathleen Romito, MD - Family Medicine, Peter J. Whitehouse, MD - Neurology |
| Editors: | Susan Van Houten, RN, BSN, MBA, Pat Truman |
© 1995-2007, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information is not intended to replace the advice of a doctor. By using AOL Body, you indicate that you have read, understood, and agreed to our Terms of Service, and AOL Body Advertising Policy. Read more about our content partners.